Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Considering the fact that two available and commonly used formulations of amphotericin B could be used instead of each other by mistake. Also, an updated and comprehensive data regarding management of this medication error was not available; the current review was conducted to gather available data among the pediatric population and discuss management and outcome of patients in case such an error occurs. We review all the cases of amphotericin B overdose which reported in PubMed and google scholar so far then discuss an 8-years-old girl diagnosed with Ewing sarcoma who inadvertently received five times more than therapeutic dose of amphotericin B deoxycholate (5mg/kg/day).In total, ten of the cases were exactly matched to our purpose of the study. In our case, fluid and electrolyte management was aggressively undertaken and she was put under cardiac monitoring for 7 days following detection of the medication error. Finally, she was discharged from hospital with stable condition. Reviewed data in this manuscript showed that amphotericin B deoxycholate overdose could cause severe complications and lead to cardio toxicity, electrolyte imbalance and death. Aggressive cardiac, fluid and electrolyte monitoring and management of any problem as soon as they were detected was the pathway followed by the authors of this review and others who faced this medication error. The role of NAC and hydrocortisone in the managing amphotericin B deoxycholate overdose requires further investigation.

Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863324253240930043642
2024-10-16
2025-09-08
Loading full text...

Full text loading...

References

  1. GrollA.H. RijndersB.J.A. WalshT.J. Adler-MooreJ. LewisR.E. BrüggemannR.J.M. Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B.Clin. Infect. Dis.201968S260S27410.1093/cid/ciz07631222253
    [Google Scholar]
  2. FukasawaM. Liposomal amphotericin B.Jpn. J. Med. Mycol.200546422923110.3314/jjmm.46.22916282964
    [Google Scholar]
  3. BadenLR. BensingerW. AngaroneM. Prevention and treatment of cancer-related infections.J. Natl. Compr. Canc. Netw.202310111412144510.6004/jnccn.2012.0146
    [Google Scholar]
  4. PappasP.G. KauffmanC.A. AndesD.R. ClancyC.J. MarrK.A. Ostrosky-ZeichnerL. ReboliA.C. SchusterM.G. VazquezJ.A. WalshT.J. ZaoutisT.E. SobelJ.D. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.Clin. Infect. Dis.2016624e1e5010.1093/cid/civ93326679628
    [Google Scholar]
  5. PattersonT.F. ThompsonG.R.III DenningD.W. FishmanJ.A. HadleyS. HerbrechtR. KontoyiannisD.P. MarrK.A. MorrisonV.A. NguyenM.H. SegalB.H. SteinbachW.J. StevensD.A. WalshT.J. WingardJ.R. YoungJ.A.H. BennettJ.E. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America.Clin. Infect. Dis.2016634e1e6010.1093/cid/ciw32627365388
    [Google Scholar]
  6. ArıkanK. Karadag-OncelE. CengizAB. Is it possible to attenuate amphotericin B-induced electrolyte imbalances in children with N-acetylcysteine?Trace Elem. Electroly.2021384193200
    [Google Scholar]
  7. PerlmanJ.M. AcarreguiM. GardJ.W. Fatal overdose of amphotericin B in two preterm infants.Dev. Pharmacol. Ther.1991173-418719010.1159/0004575211841836
    [Google Scholar]
  8. GroeneveldS. Various toxicities following inadvertent administration in paediatric patients: 2 case reports.Med. Mycol.20089954
    [Google Scholar]
  9. GroeneveldS. VerweijP.E. Van’t HekL. BökkerinkJ.P.M. WarrisA. Amphotericin B-deoxycholate overdose due to administration error in pediatric patients.Med. Mycol.200846218518710.1080/1369378070165828018324499
    [Google Scholar]
  10. KorenG. LauA. KenyonC.F. KroppertD. KleinJ. Clinical course and pharmacokinetics following a massive overdose of amphotericin B in a neonate.J. Toxicol. Clin. Toxicol.199028337137810.3109/155636590089944382231836
    [Google Scholar]
  11. FleuryM. Amphotericin-B overdose.Reactions Weekly201616051191910.1007/s40278‑016‑18243‑6
    [Google Scholar]
  12. ClearyJ.D. HaymanJ. SherwoodJ. LasalaG.P. Piazza-HeppT. Amphotericin B overdose in pediatric patients with associated cardiac arrest.Ann. Pharmacother.199327671571910.1177/1060028093027006078329789
    [Google Scholar]
  13. KarimzadehI. KhaliliH. SaghebM.M. FarsaeiS. A double-blinded, placebo-controlled, multicenter clinical trial of N -acetylcysteine for preventing amphotericin B-induced nephrotoxicity.Expert Opin. Drug Metab. Toxicol.20151191345135510.1517/17425255.2015.104236326050706
    [Google Scholar]
  14. FeldmanL. EfratiS. DishyV. KatchkoL. BermanS. AverbukhM. AladjemM. AverbukhZ. WeissgartenJ. N-acetylcysteine ameliorates amphotericin-induced nephropathy in rats.Nephron, Physiol.2004991p23p2710.1159/00008179915637469
    [Google Scholar]
  15. OdabasiZ. KaraalpA. CermikH. MohrJ. TigenE.T. KocM. KortenV. Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine.Antimicrob. Agents Chemother.20095373100310210.1128/AAC.00001‑0919414577
    [Google Scholar]
  16. BensonJ.M. NahataM.C. Pharmacokinetics of amphotericin B in children.Antimicrob. Agents Chemother.198933111989199310.1128/AAC.33.11.19892610508
    [Google Scholar]
/content/journals/cds/10.2174/0115748863324253240930043642
Loading
/content/journals/cds/10.2174/0115748863324253240930043642
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test